Continuing immunotherapy treatments when a renal cancer patient’s disease has progressed may actually do more harm than good, according to results of a new study from Los Angeles-based City of Hope researchers.
Continuing immunotherapy treatments when a renal cancer patient’s disease has progressed may actually do more harm than good, according to results of a new study from Los Angeles-based City of Hope researchers.
Copyright © 2024 | WordPress Theme by MH Themes